Reflections on the New FDA Clinical Pharmacology Guidance for Antibody-Drug Conjugates
In recent years, oncology drug developers have invested in antibody-drug conjugates (ADCs). These targeted therapies…
Jim Gallagher2024 年 5 月 10 日
CERTARA & CLOUDSCIENTIFIC ACCELERATE AI FOR DRUG DEVELOPMENT IN CHINA
Partnership will provide biopharmaceutical companies with advanced tools and solutions needed to expedite research …
Danielle Pillsbury2024 年 5 月 10 日
CERTAINTY – Japan
GREATER CERTAINTY IN DRUG DEVELOPMENT Certainty by Certara offers exclusive access to industry leaders and clinical researchers…
Danielle Pillsbury2024 年 5 月 7 日
CERTAINTY – China
GREATER CERTAINTY IN DRUG DEVELOPMENT Certainty by Certara offers exclusive access to industry leaders and clinical researchers…
Danielle Pillsbury2024 年 5 月 7 日
CERTAINTY – South Korea
GREATER CERTAINTY IN DRUG DEVELOPMENT Certainty by Certara offers exclusive access to industry leaders and clinical researchers…
Danielle Pillsbury2024 年 5 月 7 日
Certara Reports First Quarter 2024 Financial Result
Reiterates Full Year 2024 Financial Guidance PRINCETON, N.J.— May 7, 2024-- Certara, Inc. （纳斯达克股票代码：CERT), a…
Jim Gallagher2024 年 5 月 7 日
Dose Optimization Informed by PBPK Modeling: State-of-the Art and Future
The article "Dose Optimization Informed by PBPK Modeling: State-of-the Art and Future" by Karen Rowland…
Jim Gallagher2024 年 5 月 6 日
